Long-term follow-up of topiramate and lamotrigine: A perspective on quality of life

Seizure

Volumn 11, Issue 6, 2002, Pages 356-360

  Kaiser, Stefan ^a,b   Selai, Caroline E ^a   Trimble, Michael R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Audit; Lamotrigine; Outcome; QOLAS; Quality of life; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; TOPIRAMATE;

ANTICONVULSANT THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; EPILEPSY; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL AUDIT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SIDE EFFECT;

EID: 0036747264     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2002.0681     Document Type: Article

References (15)

1. Cramer, J. A., Fisher, R., Ben-Menachem, E., French, J. and Mattson, R. H. New antiepileptic drugs: comparison of key clinical trials. Epilepsia 1999; 40: 590-600.
2. Walker, M. C., Li, L. M. and Sander, J. W. Long term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome. British Medical Journal 1996; 313: 1184-1185.
3. Lhatoo, S. D., Wong, I. C., Polizzi, G. and Sander, J. W. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Epilepsia 2000; 41: 1592-1596.
4. Collins, T. L., Petroff, O. A. and Mattson, R. H. A comparsion of four new antiepileptic medications. Seizure 2000; 9: 291-293.
5. Trimble, M. R. and Dodson, W. E. Epilepsy and the Quality of Life. New York, Raven Press, 1994.
6. Hermann, B. P. The evolution of health-related quality of life assessment in epilepsy. Quality of Life Research 1995; 4: 87-100.
7. Cramer, J. A. Quality of life assessment for people with epilepsy. In: Quality of Life and Pharmacoeconomics in Clinical Trials (Ed. B. Spilker). Philadelphia, Lippincott-Raven, 1996.
8. Kline, L. N., Rentz, A. M. and Grace, E. M. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy. Epilepsia 1998; 39: 965-977.
9. Selai, C. E., Smith, K. and Trimble, M. R. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs. Seizure 1999; 8: 8-13.
10. O'Donoughe, M. F., Duncan, J. S. and Sander, J. W. The national hospital seizure severity scale: a further development of the Chalfont seizure severity scale. Epilepsia 1996; 37: 563-571.
11. Kendrick, A. M. and Trimble, M. R. Repertory grid in the assessment of quality of life in patients with epilepsy: the quality of life assessment schedule. In: Epilepsy and the Quality of Life (Eds M. R. Trimble and W. R. Dodson). New York, Raven Press, 1994.
12. Selai, C. E., Elstner, K. and Trimble, M. R. Quality of life pre and post epilepsy surgery. Epilepsy Research 2000; 38: 67-74.
13. Selai, C. E., Trimble, M. R., Rossor, M. and Harvey, R. Assessing quality of life (QOL) in dementia: preliminary psychometric testing of the quality of life assessment schedule (QOLAS). Neuropsychological Rehabilitation 2001; 11: 219-243.
14. Elstner, K., Selai, C. E., Trimble, M. R. and Robertson, M. M. Quality of life (QOL) of patients with Gilles de la Tourette's syndrome. Acta Psychiatrica Scandinavica 2001; 103: 52-59.
15. Cramer, J. A., Arrigo, C., Van Hammee, G., Gauer, L. J. and Cereghino, J. J. Effect of levetiracetam on epilepsy-related quality of life. N132 study group. Epilepsia 2000; 41: 868-874.